• Renovare targets osteoarthritis with regenerative therapies

    Renovare targets osteoarthritis with regenerative therapies

    Boulder startup restored joint tissue in animal studies after single treatment

    Renovare Therapeutics Inc. launched in early April to pursue breakthrough osteoarthritis regenerative therapies, one of which fully restored joint tissues in animal studies in as little as four to eight weeks following a single injection.

    By

Latest news